SAVIMS

Vaccine safety & adverse events

COVID-19, Covid-19 vaccines, Other scientific evidence, Resource Type, Vaccine safety & adverse events, Vaccines, Viral illnesses

Vascular and Organ Damage Induced by mRNA Vaccines: Causality Evidence

Reference: Palmer, M., & Bhakdi, S. (2022). Vascular and organ damage induced by mRNA vaccines: Irrefutable proof of causality. doctors4covidethics.org. Summary: The article by Palmer and Bhakdi presents compelling evidence regarding the adverse effects of mRNA vaccines, particularly focusing on their widespread distribution and subsequent impact on organ health. Key findings reveal that mRNA vaccines […]

COVID-19, Covid-19 vaccines, Excess deaths, Other scientific evidence, Resource Type, Statistical evidence, Vaccine safety & adverse events, Vaccines, Viral illnesses

Impact of COVID-19 Vaccination Campaign on Mortality in the USA

Reference: Rancourt, D. G., Baudin, M., & Mercier, J. (2022). COVID-Period Mass Vaccination Campaign and Public Health Disaster in the USA: From age/state-resolved all-cause mortality by time, age-resolved vaccine delivery by time, and socio-geo-economic data. Preprint. Retrieved from https://www.medrxiv.org/ Summary: This article examines the impact of the COVID-19 vaccination campaign on all-cause mortality in the

COVID-19, Covid-19 vaccines, Peer-reviewed evidence, Resource Type, Vaccine safety & adverse events, Vaccines, Viral illnesses

Serious Adverse Events of Special Interest Following mRNA COVID-19 Vaccination in Randomised Trials

Reference: Fraiman, J., Erviti, J., Jones, M., Greenland, S., Whelan, P., Kaplan, R. M., & Doshi, P. (2022). Serious adverse events of special interest following mRNA COVID-19 vaccination in randomised trials in adults. Vaccine, 40(5), 649-659. https://doi.org/10.1016/j.vaccine.2022.08.036 Summary: This article assesses serious adverse events (SAEs) associated with mRNA COVID-19 vaccines (Pfizer and Moderna) through a

COVID-19, Peer-reviewed evidence, Resource Type, Vaccine safety & adverse events, Vaccines, Viral illnesses

Serious Adverse Events Following mRNA COVID-19 Vaccination: An Analysis of Randomised Trials

Reference: Fraiman, J., Erviti, J., Jones, M., Greenland, S., Whelan, P., Kaplan, R. M., & Doshi, P. (2022). Serious adverse events of special interest following mRNA COVID-19 vaccination in randomised trials in adults. Vaccine, 40(1), 1-9. https://doi.org/10.1016/j.vaccine.2022.08.036 Summary: This article examines the serious adverse events (SAEs) associated with mRNA COVID-19 vaccines (Pfizer and Moderna) as

COVID-19, Covid-19 vaccines, Other scientific evidence, Resource Type, Vaccine effectiveness, Vaccine safety & adverse events, Vaccines, Viral illnesses

Evaluation of BNT162b2 Vaccine for Children Aged 5-11 in South Africa

Reference: South African National Department of Health. (2022). Rapid review report for COVID-19 vaccine 5–11-year-old children: Should the BNT162b2 COVID-19 vaccine be used for children aged 5 -11 years old in South Africa. Summary: A rapid review evaluated the efficacy and safety of the BNT162b2 COVID-19 vaccine for children aged 5-11 in South Africa. The

COVID-19, Covid-19 vaccines, Excess deaths, Other scientific evidence, Statistical evidence, Vaccine effectiveness, Vaccine safety & adverse events, Vaccines, Viral illnesses

Criminal Claim Filed Against Swissmedic Regarding mRNA Vaccines

Reference: Kruse, P. (2022). Swissmedic criminal claim – Executive summary. K R U S E | L A W. Retrieved from https://coronacomplaint.ch/ Summary: The article details a criminal claim involving 37 complainants and six private claimants against Swissmedic regarding the mRNA vaccines. It asserts that the administration of these vaccines poses a significant health risk,

COVID-19, Covid-19 vaccines, Other scientific evidence, Resource Type, Vaccine safety & adverse events, Vaccines, Viral illnesses

Cumulative and interval summary of adverse reactions (Pfizer – 2022)

Reference: Pfizer. (2022). Cumulative and interval summary tabulation of serious and non-serious adverse reactions from post-marketing data sources BNT162B2. Summary: The document presents a comprehensive analysis of cumulative and interval data on serious and non-serious adverse reactions associated with the BNT162B2 vaccine up to June 18, 2022. It details a total of 1,485,027 cases cumulatively,

COVID-19, Covid-19 vaccines, Other scientific evidence, Resource Type, Vaccine safety & adverse events, Vaccines, Viral illnesses

SA VAERS: Empowering Voices on Vaccine Adverse Events

Reference: Unknown. (2022). SA VAERS: An independent alternative vaccine adverse events reporting system. Retrieved from https://savaers.co.za/ Summary: SA VAERS is an independent vaccine adverse events reporting system aimed at providing a platform for survivors and victims of negative effects from the COVID-19 vaccine. Managed by Transformative Health Justice, the system focuses on enhancing data transparency

COVID-19, Covid-19 vaccines, Ivermectin, Other scientific evidence, Treatment, Vaccine effectiveness, Vaccine safety & adverse events, Vaccines, Viral illnesses

I-RECOVER: Post-Vaccine Treatment Protocol Overview

Reference: Kory, P., Marik, P., et al. (2022). I-RECOVER: Post-Vaccine Treatment protocol. Summary: The I-RECOVER protocol offers guidance for healthcare professionals treating patients experiencing post-vaccine syndrome, a condition with symptoms emerging or worsening following COVID-19 vaccination. Contributors, including prominent physicians, acknowledge the lack of formal recognition and classification for this syndrome by major health organisations,

Scroll to Top